Pharmaceuticals Pharma, AI, and the Case of Israel: Q&A with Matti Gill Last updated: May 28, 2024 11:02 am By bexib 0 Min Read Share SHARE The CEO of AION Labs discusses new ways to deploy AI in drug development and why Israel is becoming a hub for AI development in the pharmaceutical industry. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Who is responsible for web accessibility? Next Article Hyundai Motor India sets up first 180kW DC fast charging station in Chennai Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Central Bank of Australia announces three-year digital money plan Fintech “Hate and revenge are passed down from generation to generation like poison.” Economy Singtel to sell Dash Mobile Wallet to Western Union Fintech Economics of Health Care: A Personal Reflection Economy